Cheryl Gault serves as Executive at Rapport Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Cheryl Gault has executed 4 insider transactions totaling $342.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 26, 2025 involved selling 5,000 shares valued at $150.5K.
Cheryl Gault currently holds 171,928 shares of Rapport Therapeutics, Inc. (RAPP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cheryl Gault has been a net seller of RAPP stock. They have purchased $0 and sold $342.1K worth of shares.
Cheryl Gault's most recent insider trade was on Nov 26, 2025, when they sold 5,000 shares at $30.10 per share.
Get notified when new Form 4 filings are submitted
| $1.80 |
| Discretionary |
| Sep 8, 2025 | RAPP | $191.7K | Sale | 5,000 | $38.33 | Discretionary |
| Sep 8, 2025 | RAPP | $9.0K | Option Exercise | 5,000 | $1.80 | Discretionary |